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• DAIDS and IABS co-sponsored Vaccine Cell 
Substrates 2004
• 3 day conference, 6 themes
• 2 of those themes were Bovine (& porcine) Viruses in 
raw materials, Viral Adventitious Agent Test Methods
• One purpose of conference was to identify research 
gaps that preclude decision-making, since DAIDS is 
a funding organization that could potentially fund 
gap-filling research
• Progress on Cell Substrate policy was required to 
facilitate the development of HIV/AIDS vaccine 
candidates (novel approaches, novel vectors, novel 
cell substrates)
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Background and Context (2)
• Panel discussions led to recommendations
• Bovine (and porcine) viruses
• A systematic consideration should be given to 
the agents listed in 9 CFR with regard to 
relevance to use of animal-derived raw materials 
in production of human biologicals
• Viral Adventitious Agent Test Methods
• Sensitivity and breadth of existing tests are 
presumed from historical experience and should 
be evaluated systematically
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Bovine and Porcine Viruses
Scope and Purpose of Work
• Review literature
• To determine whether the bovine viruses specified in 
9 CFR 113.47 are capable of infecting humans or 
display human host range (e.g., by infecting human 
cells in culture or producing antibodies in natural- or 
laboratory-exposed humans)
• To determine if there are other bovine viruses of 
concern (displaying bovine and human host range) 
that could be predicted to be detected by the 9 CFR 
procedures (including CPE and HAd/HAg on 
indicator cells used in test)
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Bovine and Porcine Viruses
Scope and Purpose of Work (2)
• Review literature
• To identify porcine viruses (in addition to porcine 
parvovirus) having human host range and could 
contaminate porcine trypsin
• To predict whether these porcine viruses would be 
detected by the 9 CFR test methods
 Strictly a literature review and predictions would 
need to be verified in the laboratory – outside 
scope of project
 Included more than traditionally zoonotic viruses 
because biologicals are administered by routes 




Viruses with Bovine or
Porcine host range
Viruses with Porcine




1. Naturally infects cattle or swine
2. Antibodies detected and/or
3. Infects bovine/porcine cells in culture
1. Naturally infects humans
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3. Infects human cells in culture
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Viruses to consider for
additional evaluation
Bovine and Porcine Viruses
Results and Conclusion
• Some bovine viruses in the 9 CFR test are 
probably not important to human biologicals, but 
many more bovine and porcine viruses than are 
predicted to be detectable by the 9 CFR tests may 
be of concern
• Even within virus families, one or more members 
may be detected, but others may not
• Even within a virus type (e.g., reoviruses), it isn’t 
clear that all strains would be detected (e.g., if 
Reo-3 is detected by the specific antisera used for 
IFA, what is sensitivity to detect Reo-1 and -2?)
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Bovine and Porcine Viruses
Results and Conclusions (2)
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Bovine and Porcine Viruses
Results and Conclusion (3)
• Recommendations (alternatives)
• No change
• Modify 9 CFR tests
• Require testing of fetal bovine sera for anti-viral 
antibodies
• Require gamma irradiation of bovine sera, use 
recombinant trypsin, use serum-free or animal-
derived materials-free media
• Consider incorporating the minipool concept
• Consider additional tests for specific viruses
• Incorporate virus-family testing
• Consider using new test methods
• And more
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Bovine and Porcine Viruses
Find out more
This study is published in Biologicals 39(6)359-69 
Nov. 2011
“Evaluation Of The Human Host Range Of Bovine 
And Porcine Viruses That May Contaminate Bovine 
Serum And Porcine Trypsin Used In The 
Manufacture Of Biological Products”
Carol Marcus-Sekura, James Richardson, Nandini
Sane, Rebecca Harston, Rebecca Sheets
• CMS – BASI (sub-contract)
• JR, NS, RH – Advanced BioScience Laboratory 
(prime contractor)
• Also acknowledge:  Jack Hill, HMJF/DAIDS, Renita
Johnson-Leva, ABL
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“Routine” Adventitious Virus Tests
Scope of Work
• Systematically characterize the breadth & 
sensitivity of the “routine” adventitious virus tests
• In vivo (so-called “Inapparent Viruses” Test)
• In vitro (cell culture)
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“Routine” Adventitious Virus Tests
Purpose of Work
• Provide regulators and manufacturers with 
information needed for decision-making
• Such info normally comes from assay validation
• Provide baseline data to serve as basis of 
comparison for new methods
• Provide protocols and viral stocks to permit 
“direct” comparisons by developers of new 
methods
• Determine “value added” by in vivo methods in 
consideration of NIH’s 3 R’s policy
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“Routine” Adventitious Virus Tests
Planning Phase




• Design and methods
• Practical considerations
– Though not intended to support a regulatory filing, 
study should be conducted in accordance with Good 
Laboratory/Manufacturing Practices (GLP/GMP)
– Take a matrix (checkerboard) approach
– Selected choice of viruses
– Viral stocks must be cultured and titered, recognizing 
potential bias this introduced into study design
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“Routine” Adventitious Virus Tests
Methods
• In Vitro tests
• monolayers of at least 3 cell types, look for CPE
• tests for hemadsorption and hemagglutination
or immunofluorescence at end of culture period
• In Vivo tests
• adult and suckling mice
• when appropriate




“Routine” Adventitious Virus Tests
Breadth & Sensitivity
• These tests were developed for clinical 
diagnostics in mid-20th century
• Initially used to detect SPECIFIC adventitious 
agents
• Use expanded to broad general screening assays
• Breadth/sensitivity has not been systematically 
assessed and published
• Not validated in the manner currently developed 
assays would be required
• No regulatory requirements to do so and costly to 
do
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“Routine” Adventitious Virus Tests
Matrix (Checkerboard) approach
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“Routine” Adventitious Virus Tests
Implementation Phase
• The prime contractor, Advanced BioScience
Laboratories, awarded task to Charles River Labs to 
implement this project
• Compliant with Good Laboratory/Manufacturing 
Practices
• Experienced with routine adventitious agent 
testing
• In vivo and in vitro capabilities
• Virology expertise to prepare and characterize 
viral stocks required
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“Routine” Adventitious Virus Tests
Implementation Phase (2)
• Viral stocks prepared in cell culture
• Titered
• Characterized for purity & identity
• In vivo testing
• Test at highest concentration for breadth
• If positive, sensitivity determined by titration 
(dilutions)
• In vitro testing
• Breadth and sensitivity 
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“Routine” Adventitious Virus Tests
In Vitro Adventitious Virus Assay
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“Routine” Adventitious Virus Tests
In Vivo Adventitious Virus Assay
• Study design driven by ethical considerations
• Current acceptance criteria of 80% survival rate was 
used
• LOD was defined as the virus titer resulting in < 20% 
mortality (LD20)
• Initial study used undiluted stock virus 
• Titration study determined LD20 for each virus sample  
• multiple inoculation groups of 10 mice and 10 eggs each received 
virus at various titers (determined by in vitro titration) to see which 
resulted only in < 20% mortality
• To minimize cross-contamination
• One virus per room at any given time
• Performed in a Class II Biological Safety Cabinet
• Animals were housed in isolators in filter-topped Microisolator® 
cages in a negative pressure work area (100% exhausted) 
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“Routine” Adventitious Virus Tests
Results and Conclusions
The results can answer 
questions such as:
• Is using two human 
cell lines useful? 
• Is a 14-day in vitro 
test sufficient or are 
• Yes, MRC-5 & HeLa had 
different sensitivities, 
sometimes one was better, 
sometimes the other
• 28 days more sensitive 
28 days needed?
• Is sub-passage useful 
for suckling mouse 
test sensitivity? 
• Which is more 
sensitive – in vitro or 
in vivo? 
in some cases
• No, for the viruses 
tested
• With the exception of flu, the 
in vitro tests were always 
more sensitive, generally by 
logs, sometimes the 
difference between 
detecting and not detecting
22
“Routine” Adventitious Virus Tests
Results and Conclusion
Vero MRC-5 HeLa
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“Routine” Adventitious Virus Tests
In Vivo Adventitious Virus Assay (2)
Virus↓ 
Test→
Vero MRC-5 HeLa Suckling Mice Eggs




Coxsackie A  
6.3x106
10 ND 10 100 10^5 ND ND ND nt nt nt
Measles 0.01 0.01 10 1 0.1 0.1 nt nt ND ND ND
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LOD or LD20 values given
ND – not detected, negative at highest concentration  




0.01 0.01 0.01 0.01 100 UD ND ND nt nt nt
Influenza A  
6.3x107
UD UD UD 1 ND ND nt nt 0.1 0.01 0.001
“Routine” Adventitious Virus Tests
Outcomes/Deliverables
• Viral stocks will be made available through the 
NIAID/DAIDS Reagent Resource Support Program 
for AIDS Vaccine Development
• http://www.niaid.nih.gov/topics/hivaids/research/v
accines/resources/reagent/pages/default.aspx
• A research repository, not a regulatory authority 
control lab reagent repository
• Not international reference materials, but research 
reagents
• Protocols for virus preparation, titration, and for in 
vivo and in vitro test methods will also be made 
available
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“Routine” Adventitious Virus Tests
Future Considerations
• Provide developers of new methods with viral 
stocks/protocols/baseline data
• Complete the missing cells of the matrix
• Expand the list of viruses to new viral families
• Replicate with multiple strains of a particular virus
• Test field isolates
• Most relevant to bovine/porcine viruses and to 
products made in primary cell cultures/tissues/ 
animals
• Culture-adapted strains relevant to cell culture-derived 
products, because contaminant would best amplify 
and contaminate product, if adapted to the production 
cell culture
26
“Routine” Adventitious Virus Tests
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• Two of several NIAID-funded projects on adventitious 
agent testing highlighted in this talk
• Bovine and Porcine Viruses
– Publication in Biologicals 39(6)359-69 Nov. 2011
• “Routine” Adventitious Virus Tests
– Will be published
– Viral stocks will be available as research reagents
– Protocols will also be available
• Additional activities not highlighted
• CBER/OVRR 2010 Guidance on cell substrates
• WHO 2010 Guidance on cell substrates
• Inter-Agency Agreement with CBER
• Welcome opportunities to collaborate or continue 
progressing cell substrate, adventitious agent testing, 




“Routine” Adventitious Virus Tests
Adult Mice Test Methods
• Originally performed for purpose of detecting 
LCMV or other viruses
• >20 adult mice
• i.p. with 0.5 mL, i.c., with 0.03 mL
• Mice must survive 21 days
• >80% survival
• No sign of viral infection 
• Believed to be capable of detecting LCMV, 
coxsackieviruses, flaviviruses, rabies
30
“Routine” Adventitious Virus Tests
Suckling Mice Test Methods
• Originally performed for purpose of detecting 
Coxsackieviruses (particularly type A)
• >20 mice less than 24 hours old
• i.c., 0.01 mL, i.p., 0.1 mL
• 14 days
• Subinoculation into additional mice for 14 days
• Mice must survive
• >80% survival both inoculations
• No signs of viral infection
• Believed to be capable of detecting 
coxsackieviruses, other picornaviruses (polioviruses, 
echoviruses), alphaviruses, herpesviruses (HSV), 
flaviviruses, rabies, many murine agents, others
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“Routine” Adventitious Virus Tests
Embryonated Hens’ Eggs Test Methods
• 10-11 day-old embryos, 0.5 mL allantoic route, 3 
days, HA
• Believed to be capable of detecting orthomyxoviruses
(influenzaviruses), paramyxoviruses (mumps, 
measles, parainfluenzaviruses), alphaviruses
• 6-7 day-old embryos, 0.5 mL yolk sac route, >9 
days, survival
• Believed to be capable of detecting herpesviruses
(HSV), poxviruses, rhabdoviruses, rickettsiae, 
mycoplasmas, bacteria
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“Routine” Adventitious Virus Tests
Preparation of Virus Stocks
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“Routine” Adventitious Virus Tests
In Vivo Adventitious Virus Assay (2)
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